The World Health Organisation stated that the overall public health risk of monkeypox is assessed to be “moderate” at present. “Currently, the overall public health risk at global level is assessed as moderate considering this is the first time that monkeypox cases and clusters are reported concurrently in widely disparate WHO geographical areas, and without known epidemiological links to non-endemic …
Drug Firm Zydus Cadila has set the price of its medicine ‘Virafin' at Rs 11,995 per dose. After the DCGI's approval for use of this medicine in the treatment of moderate cases of Covid-19, the pharma giant has begun dispatching doses to its vendors. 'Virafin,' a single-use medication obtained emergency use clearance from the Drug Controller General of India, the …
Citing the case of a 30-year-old male health worker with COVID-19, the report highlights his successful treatment with Ayurveda. A team of doctors from the Delhi-based All India Institute of Ayurveda under the Ayush Ministry has found that Ayurveda interventions like Ayush kwatha and Fifatrol tablets can be effective in mild to moderate cases of COVID-19 infection in a “very …
Glenmark Pharmaceuticals Limited has announced the introduction of Favipiravir under the brand name FabiFlu in tablet form for the treatment of mild & moderate coronavirus cases in India. FabiFlu is India’s first oral antiviral drug for treatment of mild & moderate COVID-19 patients, the company said. The priority is to make the drug available to as many patients and save …
)